B. Melina Cimler

Biography

 Dr. Cimler leads our regulatory and quality organization. She has over 26 years of experience in the life science and FDA-regulated and global diagnostic industry leading regulatory, quality systems, clinical affairs, research, and product development organizations. Prior to Adaptive, Dr. Cimler served as Head of Global Quality and Vice President of Quality, Regulatory and Government Affairs at Illumina Inc. resulting in the first next generation sequencing platform (MiSeqDx) to receive FDA marketing authorization. Previously she also held leadership positions in quality, regulatory and government affairs for companies such as Beckman Coulter Inc., Abbott Molecular, Gen-Probe Inc., and C.R. Bard. Dr. Cimler holds a Ph.D. in Pharmacology from the University of Washington.

Research Interest

 Oncology